Gigstride Device for Difficulty Walking
Trial Summary
What is the purpose of this trial?
For patients with lower extremity deficits, the investigator(s) would like to assess implementing use of Gigstride ambulatory device to assess the following: * Patient satisfaction with use of ambulatory device * Effects of Gigstride device utilization on kinetics, biomechanics * Effects of Gigstride device utilization on walking speed, stair speed, stability
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the Gigstride Device treatment for difficulty walking?
Research on similar devices, like a biofeedback device for improving heel-to-toe gait in seniors, shows that such devices can effectively classify and improve walking patterns with high accuracy. Additionally, a weight-relieving walker has been shown to significantly aid patients with severe walking difficulties, suggesting that devices designed to assist with walking can be beneficial.12345
How is the Gigstride Device treatment different from other treatments for difficulty walking?
The Gigstride Device is unique because it combines real-time gait analysis with biofeedback to help improve walking patterns, unlike traditional physiotherapy which is limited to clinical settings. It uses sensors to detect and classify step quality, providing immediate feedback to the user, which can enhance rehabilitation outside of a clinical environment.26789
Research Team
Akhil Chhatre, MD
Principal Investigator
Johns Hopkins University
Eligibility Criteria
This trial is for adults over 18 with walking difficulties due to lower limb problems like osteoarthritis, spinal issues, multiple sclerosis, or foot drop. They should be using mobility aids and able to wear laced shoes. Participants must have had treatment for their mobility issue and provide consent.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the Gigstride ambulatory device to perform tasks and complete a questionnaire
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Gigstride Device
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Gigstride Corporation
Collaborator